Vascular Dementia: Causes, Symptoms, Treatment and Prevention

Vascular dementia is one of the most common types of dementia, second only to Alzheimer’s disease. It occurs when reduced blood flow …

Archimed to acquire Esperion Therapeutics in a $1.1 billion take-private deal

Investment firm Archimed has agreed to acquire Esperion Therapeutics for up to $1.1 billion, the companies announced on Friday, sending Esperion’s shares …

Stryker Corporation falls short of quarterly estimates amid softer demand for medical devices

Stryker Corporation on Thursday maintained its full-year profit outlook but fell short of Wall Street expectations for first-quarter revenue and earnings, as …

Merck & Co. surpasses quarterly sales forecasts, driven by strong growth from Keytruda

Merck & Co. said on Thursday it exceeded first-quarter sales expectations, driven by strong demand for its flagship cancer immunotherapy Keytruda, sending …

LEO Pharma agrees to acquire U.S. drug developer Replay for an upfront payment of $50 million

Danish drugmaker LEO Pharma said on Thursday it had agreed to acquire U.S.-based drug developer Replay for an upfront payment of $50 …

Seaport Therapeutics secures approximately $255 million through an upsized IPO

Drug developer Seaport Therapeutics announced on Thursday that it had raised approximately $255 million through its upsized initial public offering in the …